Exceptional Lives, Inc. – Trademark Portfolio
Entity Type: 99
Exceptional Lives, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include EXCEPTIONAL LIVES. The owner is based in Brookline, MA.
77 Heath Street
Brookline, MA 02445
Showing of trademarks Trademarks
Trademark Classifications
Exceptional Lives, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Exceptional Lives, Inc. have?
Exceptional Lives, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.
What trademark classes does Exceptional Lives, Inc. file in?
Exceptional Lives, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 44 (Medical Services), Class 42 (Computer & Scientific), Class 38 (Telecommunications). Class 35 covers advertising; business management; business administration; office functions.
What are Exceptional Lives, Inc.'s most well-known trademarks?
Exceptional Lives, Inc.'s registered trademark portfolio includes well-known marks such as EXCEPTIONAL LIVES. These are among 2 currently registered trademarks in the portfolio.
What is Exceptional Lives, Inc.'s trademark registration success rate?
Exceptional Lives, Inc. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.